{"schema_version":"secwatch.filing_event.v1","accession":"0001185185-23-000571","form_type":"8-K","ticker":"STEX","cik":"0001530766","company_name":"Streamex Corp.","filed_at":"2023-05-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.278461+00:00","generated_at":"2026-06-14T18:13:03.346821+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"BioSig raises $2.5M via PIPE of shares and warrants; issues placement agent warrant","bullets":["Sold 1,798,452 shares at $1.3905/share and warrants for 899,226 shares at $1.328/share; gross proceeds $2,500,747.51.","Warrants exercisable six months after issuance, expire 5.5 years from issuance; equal to 50% of shares sold.","Issued Laidlaw & Company (UK) Ltd. a warrant for 62,698 shares at $1.328/share as compensation for placement services.","Offered under Section 4(a)(2) and Regulation D; shares and warrants are unregistered but subject to registration rights.","Company expects to use proceeds for general corporate purposes and working capital."],"urls":{"canonical":"https://secwatch.observer/filing/0001185185-23-000571","json":"https://secwatch.observer/filing/0001185185-23-000571.json","markdown":"https://secwatch.observer/filing/0001185185-23-000571.md","text":"https://secwatch.observer/filing/0001185185-23-000571.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1530766/000118518523000571/0001185185-23-000571-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1530766/000118518523000571/biosig20230522_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T18:13:03.346821+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7d355075cbec5c2e0c9710d75dd357d2ea6c2e19","claim":"Streamex Corp. entered into Securities Purchase Agreement with certain institutional and accredited investors valued at $2,500,747.51 (effective 2023-05-16).","evidence_excerpt":"On May 16, 2023, BioSig Technologies, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain institutional and accredited investors (the “Investors”), pursuant to which the Company sold to the Investors an aggregate of 1,798,452 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”) at a purchase price of $1.3905 per share, and warrants (the “Warrants”) to purchase up to 899,226 shares of Common Stock (the “Warrant Shares” and together with the Shares and Warrants, the “Securities”), at an exercise price of $1.328 per share, that will become exercisable six months after the date of issuance and will expire five and one-half years following the date of issuance, in exchange for aggregate consideration of $2,500,747.51 (the “May PIPE”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1530766/000118518523000571/0001185185-23-000571-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain institutional and accredited investors"},{"label":"Value","value":"$2,500,747.51"},{"label":"Effective","value":"2023-05-16"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}